SMYD3 and diffuse large B-cell lymphoma: In summary, the current study revealed a new positive regulator of aerobic glycolysis, SMYD3, which is significantly overexpressed in DLBCL tissue and is positively associated with Ann Arbor stage, serum LDH level and poor prognosis and poor response to chemotherapy in patients with DLBCL.